These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5797940)

  • 1. In vitro studies with 5-fluorocytosine.
    Shadomy S
    Appl Microbiol; 1969 Jun; 17(6):871-7. PubMed ID: 5797940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antimycotic activity of 5-fluorocytosine.
    Holt RJ; Newman RL
    J Clin Pathol; 1973 Mar; 26(3):167-74. PubMed ID: 4700499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ; Perkins RL
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.
    Shadomy S; Kirchoff CB; Ingroff AE
    Antimicrob Agents Chemother; 1973 Jan; 3(1):9-14. PubMed ID: 4799552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine.
    Marks MI; Eickhoff TC
    Antimicrob Agents Chemother (Bethesda); 1970; 10():491-3. PubMed ID: 5000267
    [No Abstract]   [Full Text] [Related]  

  • 6. Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine.
    Block ER; Jennings AE; Bennett JE
    Antimicrob Agents Chemother; 1973 Oct; 4(4):392-5. PubMed ID: 4598611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.
    Medoff G; Comfort M; Kobayashi GS
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):571-4. PubMed ID: 5118468
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S; Schönebeck J
    Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorocytosine resistance in Cryptococcus neoformans.
    Block ER; Jennings AE; Bennett JE
    Antimicrob Agents Chemother; 1973 Jun; 3(6):649-56. PubMed ID: 4597734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species.
    Karlowsky JA; Zhanel GG; Balko TV; Zelenitsky SA; Kabani AM; Hoban DJ
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):179-82. PubMed ID: 9327245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
    Chin CS; Cheong YM; Wong YH
    Med J Malaysia; 1989 Sep; 44(3):194-8. PubMed ID: 2696871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic activity of 5-fluorocytosine against a lethal Candida albicans infection in mice.
    Pittillo RF; Ray BJ
    Appl Microbiol; 1969 May; 17(5):773-4. PubMed ID: 5785966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic antifungal activity of pyrrolnitrin.
    Gordee RS; Matthews TR
    Appl Microbiol; 1969 May; 17(5):690-4. PubMed ID: 5785951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of clotrimazole (Bay b 5097).
    Shadomy S
    Infect Immun; 1971 Aug; 4(2):143-8. PubMed ID: 4949484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity and resistance of Candida to 5-fluorocytosine, 5-fluorouracil and 5-fluorouridine. Relation to the ecology and serotype of C. albicans].
    Drouhet E; Mercier-Soucy L; Montplaisir S
    C R Acad Hebd Seances Acad Sci D; 1974 Jan; 278(5):605-8. PubMed ID: 4211641
    [No Abstract]   [Full Text] [Related]  

  • 20. A microautomated dilution method for susceptibility testing with antifungal drugs.
    Polonelli L; Morace G
    Mycopathologia; 1984 Apr; 86(1):21-8. PubMed ID: 6377080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.